Butler George, Amend Sarah R, Axelrod Robert, Venditti Chris, Pienta Kenneth J
Cancer Ecology Center, The Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Geral R. Ford School of Public Policy, University of Michigan, Ann Arbor, MI, USA.
bioRxiv. 2024 Apr 11:2024.04.08.588529. doi: 10.1101/2024.04.08.588529.
The evolution of metastasis represents a lethal stage of cancer progression. Yet, the evolutionary kinetics of metastatic disease remain unresolved. Here, using single cell CRISPR-Cas9 lineage tracing data, we show that in metastatic disease, gradual molecular evolution is punctuated by episodes of rapid evolutionary change associated with lineage divergence. By measuring punctuational effects across the metastatic cascade, we show that punctuational effects contribute more to the molecular diversity at distal site metastases compared to the paired primary tumor, suggesting qualitatively different modes of evolution may drive primary and metastatic tumor progression. This is the first empirical evidence for distinct patterns of molecular evolution at early and late stages of metastasis and demonstrates the complex interplay of cell intrinsic and extrinsic factors that shape lethal cancer.
转移的演变代表了癌症进展的致命阶段。然而,转移性疾病的进化动力学仍未得到解决。在这里,利用单细胞CRISPR-Cas9谱系追踪数据,我们表明,在转移性疾病中,渐进的分子进化被与谱系分化相关的快速进化变化事件所打断。通过测量转移级联中的标点效应,我们表明,与配对的原发性肿瘤相比,标点效应在远端转移部位对分子多样性的贡献更大,这表明定性不同的进化模式可能驱动原发性和转移性肿瘤的进展。这是转移早期和晚期分子进化不同模式的首个实证证据,并证明了塑造致命癌症的细胞内在和外在因素的复杂相互作用。